Understanding HIV "Treatment Cascade" Critical for Program Success
October 30, 2013
In a joint post in the Center for Global Development's (CGD) "Global Health Policy" blog, senior fellow Mead Over and research assistant Yuna Sakuma examine the issue of retention with respect to HIV treatment, which they note was discussed at the October 2 PEPFAR Scientific Advisory Board meeting. "For years even the friendliest critics of the global struggle against AIDS have pointed out that [simply counting the number of patients on treatment] unfairly neglects the people who are not put on treatment and then die, largely because their deaths are uncounted except in so far as they increase the treatment 'coverage rate,'" they write, examining the so-called "treatment cascade" and some of the data presented at the meeting. They continue, "Even if a proper measure of retention in treatment yields a less pessimistic estimate of the attrition in the treatment cascade, the enormous loss of patients throughout the treatment cascade remains a glaring reminder of the need to better understand the causes of patient loss at every stage in the cascade and how these losses can be stemmed" (10/29).
UN Special Envoy Kazatchkine Calls for Increased Efforts to Prevent HIV/AIDS Among "Key Affected Populations"
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)